|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu C, Li M, Meng H, Liu Y, Niu W, Zhou Y,
Zhao R, Duan Y, Zeng Z, Li X, et al: Analysis of status and
countermeasures of cancer incidence and mortality in China. Sci
China Life Sci. 62:640–647. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Feng A, Zheng S, Chen C and Lyu J:
Recent estimates and predictions of 5-year survival in patients
with gastric cancer: A model-based period analysis. Cancer Control.
29:107327482210992272022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
GBD 2017 Stomach Cancer Collaborators, .
The global, regional, and national burden of stomach cancer in 195
countries, 1990–2017: A systematic analysis for the global burden
of disease study 2017. Lancet Gastroenterol Hepatol. 5:42–54. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsukamoto T, Nakagawa M, Kiriyama Y,
Toyoda T and Cao X: Prevention of gastric cancer: Eradication of
Helicobacter pylori and beyond. Int J Mol Sci. 18:16992017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang
Y, Yi C, Lindahl T, Pan T, Yang YG and He C: N6-methyladenosine in
nuclear RNA is a major substrate of the obesity-associated FTO. Nat
Chem Biol. 7:885–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu
H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting
of oncogenic FTO demethylase in acute myeloid leukemia. Cancer
Cell. 35:677–691.e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y, Ye S, Zhang N, Zheng S, Liu H, Zhou
K, Wang L, Cao Y, Sun P and Wang T: The FTO/miR-181b-3p/ARL5B
signaling pathway regulates cell migration and invasion in breast
cancer. Cancer Commun (Lond). 40:484–500. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang H, Wang Y, Kandpal M, Zhao G,
Cardenas H, Ji Y, Chaparala A, Tanner EJ, Chen J, Davuluri RV and
Matei D: FTO-Dependent N (6)-Methyladenosine modifications inhibit
ovarian cancer stem cell self-renewal by blocking cAMP signaling.
Cancer Res. 80:3200–3214. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue C, Chen J, Li Z, Li L, Chen J and Guo
Y: MicroRNA-96 promotes occurrence and progression of colorectal
cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. J Exp Clin
Cancer Res. 39:2402020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su Y, Huang J and Hu J: M6A RNA
methylation regulators contribute to malignant progression and have
clinical prognostic impact in gastric cancer. Front Oncol.
9:10382019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimura T, Kandimalla R, Okugawa Y, Ohi M,
Toiyama Y, He C and Goel A: Novel evidence for m(6)A methylation
regulators as prognostic biomarkers and FTO as a potential
therapeutic target in gastric cancer. Br J Cancer. 126:228–237.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Y, Yan X, Wang Y, Zhou J and Yu Y:
Denocarcinoma. Front Oncol. 11:7260182022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu D, Shao W, Jiang Y, Wang X, Liu Y and
Liu X: FTO expression is associated with the occurrence of gastric
cancer and prognosis. Oncol Rep. 38:2285–2292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun
L, Wang Y, Li X, Xiong XF, Wei B, et al: RNA N6-methyladenosine
demethylase FTO promotes breast tumor progression through
inhibiting BNIP3. Mol Cancer. 18:462019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Long NY, Xiong L, Zhao Y, Yuan H, Li YJ,
Chen XS, Zhang XY, Xie Y and Zhou JJ: Sequences difference of CagA
between East Asian strain and Western strain of Helicobacter
pylori and its impact on the proliferation and apoptosis.
Microbiology. 45:848–855. 2018.(In Chinese).
|
|
17
|
Zhao Y, Xie Y, Chen X, Xu W, Wang Y and
Zhou J: Establishment of Mongolian gerbil model of gastric cancer
induced by Helicobacter pylori infection and its proteomics
analysis. Zhonghua Bing Li Xue Za Zhi. 43:820–826. 2014.(In
Chinese). PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th edition.
Springer International Publishing; New York, NY: 2017, View Article : Google Scholar
|
|
20
|
Amieva M and Peek RM JR: Pathobiology of
Helicobacter pylori-induced gastric cancer.
Gastroenterology. 150:64–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Correa P: Human gastric carcinogenesis: A
multistep and multifactorial process-first american cancer society
award lecture on cancer epidemiology and prevention. Cancer Res.
52:6735–6740. 1992.PubMed/NCBI
|
|
22
|
Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang
X, Li H, Li Q, Wang N and Ji J: Gastric cancer: Epidemiology, risk
factors and prevention strategies. Chin J Cancer Res. 32:695–704.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loor A and Dumitraşcu DL: Helicobacter
pylori infection, gastric cancer and gastropanel. Rom J Intern
Med. 54:151–156. 2016.PubMed/NCBI
|
|
24
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Outlioua A, Badre W, Desterke C, Echarki
Z, El Hammani N, Rabhi M, Riyad M, Karkouri M, Arnoult D, Khalil A
and Akarid K: Gastric IL-1β, IL-8, and IL-17A expression in
Moroccan patients infected with Helicobacter pylori may be a
predictive signature of severe pathological stages. Cytokine.
126:1548932020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rasool KH, Alubadi AE and Al-Bayati IFI:
The role of serum interleukin-4 and interleukin-6 in
Helicobacter pylori-infected patients. Microb Pathog.
162:1053622022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gonciarz W, Krupa A, Hinc K, Obuchowski M,
Moran AP, Gajewski A and Chmiela M: The effect of Helicobacter
pylori infection and different H. pylori components on the
proliferation and apoptosis of gastric epithelial cells and
fibroblasts. PLoS One. 14:e02206362019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mera RM, Bravo LE, Camargo MC, Bravo JC,
Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG,
Morgan DR, et al: Dynamics of Helicobacter pylori infection
as a determinant of progression of gastric precancerous lesions:
16-year follow-up of an eradication trial. Gut. 67:1239–1246. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ernst PB, Peura DA and Crowe SE: The
translation of Helicobacter pylori basic research to patient
care. Gastroenterology. 130:188–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Infection with Helicobacter pylori.
IARC Monogr Eval Carcinog Risks Hum. 61:177–240. 1994.PubMed/NCBI
|
|
31
|
Battaglin F, Naseem M, Puccini A and Lenz
HJ: Molecular biomarkers in gastro-esophageal cancer: Recent
developments, current trends and future directions. Cancer Cell
Int. 18:992018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dina C, Meyre D, Gallina S, Durand E,
Körner A, Jacobson P, Carlsson LMS, Kiess W, Vatin V, Lecoeur C, et
al: Variation in FTO contributes to childhood obesity and severe
adult obesity. Nat Genet. 39:724–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J and Du B: Novel positioning from
obesity to cancer: FTO, an m(6)A RNA demethylase, regulates tumour
progression. J Cancer Res Clin Oncol. 145:19–29. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zou D, Dong L, Li C, Yin Z, Rao S and Zhou
Q: The m(6)A eraser FTO facilitates proliferation and migration of
human cervical cancer cells. Cancer Cell Int. 19:3212019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deng X, Su R, Stanford S and Chen J:
Critical enzymatic functions of FTO in obesity and cancer. Front
Endocrinol (Lausanne). 9:3962018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Wan Y, Zhang Z, Jiang Y, Lang J,
Cheng W and Zhu L: FTO demethylates m6A modifications in HOXB13
mRNA and promotes endometrial cancer metastasis by activating the
WNT signalling pathway. RNA Biol. 18:1265–1278. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang X, Liu S, Chen D, Zhao Z and Zhou J:
The role of the fat mass and obesity-associated protein in the
proliferation of pancreatic cancer cells. Oncol Lett. 17:2473–2478.
2019.PubMed/NCBI
|
|
38
|
Chen D, Li C, Zhao Y, Zhou J, Wang Q and
Xie Y: 2021. Bioinformatics analysis for the identification of
differentially expressed genes and related signaling pathways in H.
pylori-CagA transfected gastric cancer cells. PeerJ. 9:e112032021.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hou S, Shan M, Gao C, Feng X, Yang Y,
Zhang R, He Y, Zhang G and Zhang L: PCDHGB7 increases
chemosensitivity to carboplatin by inhibiting HSPA9 via inducing
apoptosis in breast cancer. Dis Markers. 2019:61315482019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang
Y, Huang C, Fan S, Chen P, Yao X, et al: A novel
miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation,
metabolism and tumorigenesis. Theranostics. 10:7193–7210. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang S and Huo X: Comprehensive analysis
of ESRRA in endometrial cancer. Technol Cancer Res Treat.
20:15330338219920832021.PubMed/NCBI
|
